A legacy of mentorship continues and expands: over three decades of Young Investigators of the Year; the Paul Carbone, MD Fellowship turns 20; and the Group honors its second Remarkable Mentor to ...
The FEATURE study provides the first prospective validation of FDG-PET/CT and PERCIST response criteria in patients presenting with bone-only or bone-dominant metastatic breast cancer, opening the ...
The MarketWatch News Department was not involved in the creation of this content. New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger ...
The long-awaited report of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network (ECOG-ACRIN) 1308 study, 1 although interesting, was troubling for numerous reasons, ...
IRVING, Texas, June 7, 2017 /PRNewswire/ -- Caris Life Sciences ®, a leading innovator in molecular science, today announced a collaboration with the National Cancer Institute (NCI) for the ...
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has enrolled the first patient in a new treatment trial to evaluate the effectiveness of adding nilotinib to standard paclitaxel chemotherapy. The ...
The positions in the table below reflect the ECOG-ACRIN Cancer Research Group's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results